Zyga gets $10M boost, expects CE mark for Glyder device by year's end

12/17/2013 | Medical Device & Diagnostic Industry online

A funding round has pulled in $10 million for Zyga Technology, maker of the FDA-cleared SImmetry Sacroiliac Joint Fusion System designed to treat hip and lower back pain. The company also hopes to obtain CE mark approval in Europe for its Glyder Facet Resurfacing System, which is used to treat chronic facetogenic pain, by the close of the year.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA